Acne
Commentary
The Growing Pains of Changing Times for Acne and Rosacea Pathophysiology: Where Will It All End Up?
Although acne vulgaris (AV) and rosacea do not make front-page news quite as often as some of these other aforementioned disease states in the...
Case Reports
Long-term Remission of Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome
When formulating therapeutic regimens for patients with PASH syndrome, it is essential for dermatologists to consider the likelihood of...
Photo Challenge
Papular Acneform Eruption With Mucositis
A 48-year-old man with a history of ulcerative colitis that was well-controlled with adalimumab presented with a generalized acneform eruption...
Photo Challenge
Persistent Wounds Refractory to Broad-Spectrum Antibiotics
A 28-year-old Black woman presented to the hospital for evaluation of worsening leg wounds as well as a similar eroding plaque on the left breast...
Latest News
Picosecond laser applications continue to expand
“In 2023, we’re better than we’ve ever been in terms of our ability to safely and effectively improve melasma,” Dr. Paul M. Friedman said.
Latest News
1,726-nm lasers poised to revolutionize acne treatment, expert predicts
“Further study of both scarring and acne are needed to fully categorize the benefit and to optimize treatments,” Dr. Jeffrey Dover said.
Conference Coverage
Could combining topical antioxidants with a nonablative laser prevent acne scars?
“If we can prevent or treat PIH, we may be able to prevent scarring,” Dr. Jill S. Waibel said.
Cosmeceutical Critique
Bergamot
Beyond its niche role in treatments for vitiligo and psoriasis, this botanical product appears to show potential as an anti-inflammatory agent as...
Latest News
Frustration over iPLEDGE evident at FDA meeting
Dermatologists argue the iPLEDGE REMS burden is too high for providers and patients. Access problems persist with lockouts and some cite a lack of...
Latest News
FDA panels vote to modify isotretinoin iPLEDGE REMS
The committees sought to balance reducing burden with maintaining safety and preventing fetal exposures to isotretinoin.
Latest News
FDA Advisory panels consider easing isotretinoin requirements
The 2-day meeting is addressing what can be done to reduce burden with the iPLEDGE REMS while maintaining safety and preventing fetal exposure to...